It is a financial services private limited company based in Hyderabad, Telangana, India, established in 2016.
2016 | Hyderabad, Telangana, India | AmalgamatedNeovantage Bio-Technology Private Limited, a amalgamated private limited company, was established on 09 July 2016 in Hyderabad, Telangana, India. Engaging in real estate financing within the construction sector, it holds CIN: U74999TG2016PTC110776. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹12.50 Cr and a paid-up capital of ₹9.82 Cr.
It upholds a compliant status. Its leadership includes Shilpi Chowdhary (Director), Chandan Kumar Mishra (Additional Director). Past directors included Amrendra Kumar Singh, Barbie Saurabhkumar Singh, Rajesh Sundaresan. It holds ₹63.00 Cr open charges and ₹361.60 Cr settled loans. Its latest AGM occurred on 26 September 2024, with the balance sheet filed on 31 March 2024. It is based at Building-450, Genome Valley, Turkapally (V), Shamirpet Mandal, Hyderabad, Telangana, 500078.
U74999TG2016PTC110776
110776
09 July 2016
₹12.50 Cr
₹9.82 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Neovantage Bio-Technology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shilpi Chowdhary | Director | 10 Jul 2018 | Current |
| Chandan Kumar Mishra | Additional Director | 17 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Ceo(Kmp) | 08 Mar 2019 | Past |
| Pramod Abcsdd | Company Secretary | 03 May 2018 | Past |
| Pramod Abcsdd | Director | 24 Sep 2020 | Past |
| Pramod Abcsdd | Director | 19 Sep 2016 | Past |
| Pramod Abcsdd | Director | 10 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neovantage Bio-Technology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 146.35% increase. The company also saw a substantial fall in profitability, with a 21.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Neovantage Bio-Technology had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹630,000,000.00
₹3,616,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2019 | Others | ₹69.60 Cr | Satisfied |
| 07 Sep 2018 | Others | ₹70.00 Cr | Satisfied |
| 27 Sep 2016 | Idbi Trusteeship Services Limited | ₹54.50 Cr | Satisfied |
| 27 Sep 2016 | Idbi Trusteeship Services Limited | ₹167.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Neovantage Bio-Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neovantage Bio-Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neovantage Bio-Technology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Chandan Kumar Mishra was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2024 & has been associated with this company since 1 year 1 month . was completed.
Neovantage Bio-Technology Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Neovantage Bio-Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity A charge registered on 17 Dec 2019 via Charge ID 100314853 with Others was fully satisfied on 21 Sep 2022. was completed.
Progress on A charge with Others of Rs. 69.60 Cr registered on 17 Dec 2019 with Charge ID 100314853 was modified on 19 Oct 2020. was documented.
A charge registered on 07 Sep 2018 via Charge ID 100203201 with Others was fully satisfied on 17 Jan 2020. was recorded as a recent event.
The CIN of Neovantage Bio-Technology Private Limited is U74999TG2016PTC110776.
Neovantage Bio-Technology Private Limited is headquartered at Building-450, Genome Valley, Turkapally (V), Shamirpet Mandal, Hyderabad, Telangana, 500078.
Neovantage Bio-Technology Private Limited was incorporated on 09 July 2016.
The current directors of Neovantage Bio-Technology Private Limited are
The primary industry of Neovantage Bio-Technology Private Limited is Construction.
Neovantage Bio-Technology Private Limited is unlisted.
The authorized capital of Neovantage Bio-Technology Private Limited is ₹12.50 Cr, and the paid-up capital is ₹9.82 Cr.
The compliance status of Neovantage Bio-Technology Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX